FI921146A0 - Ett foerfarande foer snabb radioaktiv markering av monovalentiska antibodyfragmenter med teknetium. - Google Patents

Ett foerfarande foer snabb radioaktiv markering av monovalentiska antibodyfragmenter med teknetium.

Info

Publication number
FI921146A0
FI921146A0 FI921146A FI921146A FI921146A0 FI 921146 A0 FI921146 A0 FI 921146A0 FI 921146 A FI921146 A FI 921146A FI 921146 A FI921146 A FI 921146A FI 921146 A0 FI921146 A0 FI 921146A0
Authority
FI
Finland
Prior art keywords
antibody fragment
teknetium
monovalentiska
markering
antibodyfragmenter
Prior art date
Application number
FI921146A
Other languages
English (en)
Other versions
FI921146A (fi
Inventor
Hans J Hansen
Anastasia Lentine-Jones
Original Assignee
Immunomedics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunomedics Inc filed Critical Immunomedics Inc
Publication of FI921146A publication Critical patent/FI921146A/fi
Publication of FI921146A0 publication Critical patent/FI921146A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
FI921146A 1989-09-18 1992-03-17 Ett foerfarande foer snabb radioaktiv markering av monovalentiska antibodyfragmenter med teknetium. FI921146A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40824189A 1989-09-18 1989-09-18
PCT/US1990/005196 WO1991004056A1 (en) 1989-09-18 1990-09-18 Method for rapidly radiolabeling monovalent antibody fragments with technetium

Publications (2)

Publication Number Publication Date
FI921146A FI921146A (fi) 1992-03-17
FI921146A0 true FI921146A0 (fi) 1992-03-17

Family

ID=23615452

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921146A FI921146A0 (fi) 1989-09-18 1992-03-17 Ett foerfarande foer snabb radioaktiv markering av monovalentiska antibodyfragmenter med teknetium.

Country Status (15)

Country Link
EP (1) EP0419203B1 (fi)
JP (1) JPH0723326B2 (fi)
KR (1) KR960015611B1 (fi)
AT (1) ATE110281T1 (fi)
AU (1) AU640698B2 (fi)
CA (1) CA1340250C (fi)
DE (1) DE69011789T2 (fi)
DK (1) DK0419203T3 (fi)
ES (1) ES2063286T3 (fi)
FI (1) FI921146A0 (fi)
IE (1) IE64399B1 (fi)
IL (1) IL95723A (fi)
NO (1) NO920853D0 (fi)
WO (1) WO1991004056A1 (fi)
ZA (1) ZA907420B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346687A (en) * 1989-08-09 1994-09-13 Rhomed Incorporated Direct radiolabeling of antibody against stage specific embryonic antigen for diagnostic imaging
US5460785A (en) * 1989-08-09 1995-10-24 Rhomed Incorporated Direct labeling of antibodies and other protein with metal ions
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
EP0498333B1 (de) * 1991-02-05 1997-01-15 Cis Bio International Verfahren zur Herstellung einer mit Technetium-99m markierten organspezifischen Substanz
AU658403B2 (en) * 1991-02-27 1995-04-13 Akzo N.V. Technetium-99m labeling of proteins
ZA955642B (en) * 1994-07-07 1997-05-06 Ortho Pharma Corp Lyophilized imaging agent formulation
US5942210A (en) * 1994-11-15 1999-08-24 Cytogen Corporation Methods for lyoprotecting a macromolecule using tricine
US6080384A (en) * 1997-03-25 2000-06-27 American Biogenetic Sciences, Inc. Methods for radionuclide-labeling of biomolecules and kits utilizing the same
WO1999012579A1 (en) * 1997-09-08 1999-03-18 The General Hospital Corporation Imaging agents for early detection and monitoring of cardiovascular plaque
US7060251B1 (en) 1997-09-08 2006-06-13 The General Hospital Corporation Imaging agents for early detection and monitoring of cardiovascular plaque
EP1419786A1 (en) * 2002-11-13 2004-05-19 Bracco Imaging S.p.A. Method for the selective and quantitative functionalization of immunoglobulin fab fragments, conjugate compounds obtained with the same and compositions thereof
ITMI20022411A1 (it) * 2002-11-14 2004-05-15 Bracco Imaging Spa Agenti per la diagnosi e la terapia di tumori che espongono sulla superficie delle cellule proteine alterate.
JP2008503493A (ja) * 2004-06-17 2008-02-07 アナザオヘルス コーポレーション 腫瘍を破壊するための安定化され凍結乾燥された放射性薬剤
US7229603B2 (en) * 2004-06-17 2007-06-12 Anazaohealth Corporation Stablilized and lyophilized radiopharmaceutical agents
EP1894577A4 (en) * 2005-06-14 2012-03-28 Nihon Mediphysics Co Ltd RADIOACTIVE DIAGNOSTIC IMAGING DAY

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725295A (en) * 1971-07-20 1973-04-03 Atomic Energy Commission Technetium labeling
US4057617A (en) * 1975-05-15 1977-11-08 Abramovici J Method of labeling proteins with technetium
US4062933A (en) * 1975-05-27 1977-12-13 Mallinckrodt, Inc. Colloidal compositions with protective agents suitable for radioactive labeling
US4323546A (en) * 1978-05-22 1982-04-06 Nuc Med Inc. Method and composition for cancer detection in humans
US4293537A (en) * 1978-09-05 1981-10-06 Wong Dennis W Novel chemical method of labeling proteins with 99m Tc-Technetium at physiological condition
US4472371A (en) * 1979-10-29 1984-09-18 Summa Medical Corporation Radiolabeled antibody to anti-tumor associated antigen and process
US4311688A (en) * 1979-10-29 1982-01-19 Serono Laboratories Inc. Composition and method for cancer detection in humans
USRE32417E (en) * 1979-10-29 1987-05-12 Summa Medical Corporation Radiolabeled antibody to anti-tumor associated antigen and process
US4401647A (en) * 1980-03-03 1983-08-30 The Regents Of The University Of Ca Radiolabeled neoglycopeptides
US4500507A (en) * 1981-10-30 1985-02-19 Wong Dennis W Diagnostic composition for radiologic imaging of neoplasms in the body and method of preparation
JPS5967228A (ja) * 1982-10-07 1984-04-16 Green Cross Corp:The 寒冷不溶性グロブリンの凍結乾燥方法
US4877868A (en) * 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
WO1988007382A2 (en) * 1987-04-02 1988-10-06 Centocor Cardiovascular Imaging Partners, L.P. Method for labelling antibodies with a metal ion
US5061641A (en) * 1988-04-01 1991-10-29 Immunomedics, Inc. Method for radiolabeling proteins

Also Published As

Publication number Publication date
FI921146A (fi) 1992-03-17
IL95723A (en) 1995-08-31
ES2063286T3 (es) 1995-01-01
NO920853L (no) 1992-03-04
DK0419203T3 (da) 1994-12-05
ZA907420B (en) 1991-07-31
CA1340250C (en) 1998-12-15
NO920853D0 (no) 1992-03-04
IL95723A0 (en) 1991-06-30
ATE110281T1 (de) 1994-09-15
KR960015611B1 (ko) 1996-11-18
AU6521490A (en) 1991-04-18
KR920703111A (ko) 1992-12-17
AU640698B2 (en) 1993-09-02
IE64399B1 (en) 1995-08-09
EP0419203A1 (en) 1991-03-27
WO1991004056A1 (en) 1991-04-04
IE903360A1 (en) 1991-04-10
EP0419203B1 (en) 1994-08-24
JPH0723326B2 (ja) 1995-03-15
DE69011789D1 (de) 1994-09-29
JPH04505455A (ja) 1992-09-24
DE69011789T2 (de) 1994-12-15

Similar Documents

Publication Publication Date Title
FI921146A (fi) Ett foerfarande foer snabb radioaktiv markering av monovalentiska antibodyfragmenter med teknetium.
ATE47214T1 (de) Formbarer und biegbarer, knickbarer dichter schlauch und verfahren zu seiner herstellung.
DE69018758T2 (de) Therapeutische Gegenstände aus Polytetrafluorethylen.
SE9002522L (sv) Metod foer framstaellning av en farmaceutisk komposition i form av mikropartiklar
NO883926L (no) Fremgangsmaate for fremstilling av stabilisert humanproteinpreparat.
ATE117434T1 (de) Gefriergetrocknete zusammensetzung, die ein mit meerrettichperoxydase markiertes fab'-fragment eines gegen menschliches beta-interferon gerichteten antikörpers und trehalose enthält; eia kit, der diese zusammensetzung enthält.
ATE79283T1 (de) Injektionsgeraet mit einem spannglied und mit einem zweiten stellglied.
ATE149515T1 (de) Verfahren zur markierung von proteinen mit technetium/rhenium
DE3783745D1 (de) Verfahren zur herstellung einer mit technetium-99m-markierten organspezifischen substanz.
FI882380A0 (fi) Synnerligen aktiva, lineaera och cykliska analoger av alfa-msh-fragment.
DE68909928D1 (de) Struktur mit orientierten fasern und verfahren zur herstellung.
ATE88129T1 (de) Verfahren zur herstellung von aus kueken und gehaeuse bestehendem haehnchen fuer medizinische geraete.
DE3773077D1 (de) Immunotoxine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3688204T2 (de) Monoklonaler antikoerper gegen ein p21-bezuegliches dodekapeptid des ras-onkogens.
DK0591710T3 (da) Injektionsopløsninger indeholdende mesna
DE3885752D1 (de) Methode und verbindungen zur herstellung von acsf und acsf-antagonisten.
DE68919758T2 (de) Antikörper gegen Fibrin, Immunogen zur Herstellung desselben, Verfahren zur Bestimmung von Fibrin und pharmazeutisches Präparat auf Basis der Antikörper.
IL86443A0 (en) Protein absorption enhancing agents
DE69107850T2 (de) Verfahren zur Herstellung und 99mTc-Markierung von 2-alkoxyisobutylisonitrile.
DE58902684D1 (de) Verfahren zur herstellung von cyclischen n,n'-dimethylharnstoffen.
ATE40795T1 (de) Verwendung eines zerebral und peripher wirkenden antihypoxidotikums.
DE69008859D1 (de) Modifizierte menschliche anti-rh(d)-antikörper.
ATE95850T1 (de) Struktur mit orientierten fasern und verfahren zur herstellung.
BG50927A3 (en) A process for stabilisied growth-stimulating hormone preparation
ATE101249T1 (de) Flasche mit konkavboden und verfahren zur herstellung derselben.

Legal Events

Date Code Title Description
FD Application lapsed